kabutan

SANTEN PHARMA, Apr-Jun (1Q) Net Income Decreases by 45%

Thu Aug 7, 2025 3:30 pm JST Earnings

4536 SANTEN PHARMACEUTICAL CO.,LTD. 【IFRS】

Earnings Report

SANTEN PHARMACEUTICAL CO.,LTD. <4536> [TSE Prime] announced its financial results (based on IFRS) after the market closed on August 7th (15:30). The consolidated net income for the first quarter of the fiscal year ending March 2026 (April to June) dropped 44.7% from the same period last year to 5.87 billion yen. Progress toward the full-year plan of 34.0 billion yen was 17.3%, also falling below the five-year average of 40.5%.

In the most recent three-month period, from April to June (1Q), the operating profit margin significantly dropped from 17.6% in the same period last year to 11.0%.

Kabutan News

Actual Results

Accumulated Results 1st Quarter
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Progress Rate vs. First Half Announce Accounting Standards
Apr - Jun, 2023 72,389 12,750 12,868 10,414 27.9 53.4 Aug 3, 2023 IFRS
Apr - Jun, 2024 74,771 13,155 13,450 10,633 29.6 56.4 Aug 6, 2024 IFRS
Apr - Jun, 2025 68,737 7,573 7,450 5,878 17.3 ー Aug 7, 2025 IFRS
YoY -8.1% -42.4% -44.6% -44.7% -41.5%

Guidance Update

Full Year Update

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Mar, 2026 Prev 294,000 44,000 33,500 34,000 105.7 38 May 13, 2025 IFRS
Mar, 2026 New 294,000 44,000 ー 34,000 105.7 38 Aug 7, 2025 IFRS
Revision Rate 0.0% 0.0% － 0.0% 0.0%

Current Period Guidance

H1 Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Apr - Sep, 2024 146,404 23,873 23,839 18,772 52.9 17 Nov 7, 2024 IFRS
Apr - Sep, 2025 Guidance ー ー ー ー － 19 May 13, 2025 IFRS
YoY － － － － －

Current Period Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Mar, 2024 301,965 38,541 29,874 26,642 72.6 33 May 9, 2024 IFRS
Mar, 2025 300,004 46,880 47,481 36,256 104.0 36 May 13, 2025 IFRS
Mar, 2026 Guidance 294,000 44,000 ー 34,000 105.7 38 Aug 7, 2025 IFRS
YoY -2.0% -6.1% － -6.2% +1.7%

Quarterly Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Operating Profit Margin Announce Accounting Standards
Apr - Jun, 2024 74,771 13,155 13,450 10,633 29.6 17.6 Aug 6, 2024 IFRS
Jul - Sep, 2024 71,633 10,718 10,389 8,139 22.9 15.0 Nov 7, 2024 IFRS
Oct - Dec, 2024 76,369 11,322 11,470 8,693 24.8 14.8 Feb 6, 2025 IFRS
Jan - Mar, 2025 77,231 11,685 12,172 8,791 25.2 15.1 May 13, 2025 IFRS
Apr - Jun, 2025 68,737 7,573 7,450 5,878 17.3 11.0 Aug 7, 2025 IFRS
YoY -8.1% -42.4% -44.6% -44.7% -41.5%

Related Articles